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Thoracoabdominal esophagectomy, which is one of 
the most invasive surgical procedures, often causes 
postoperative fever and high C-­reactive protein 
(CRP) level.  Both of these symptoms are frequently 
XVHGDVLQGLFDWRUVRIWKHLQÁDPPDWRU\UHVSRQVHDW
the bedside.  A recent report showed that fever was 
independently associated with mor tal i ty in non-­sep-­
tic patients including those who have undergone 
surgery17).  The CRP level is markedly increased by 
surgical procedures.  The more invasive the surgical 
procedure, the more the CRP level increases10, 28). 
In addition, the CRP levels on postoperative days 
(POD) 2-­4 have proven to be useful for predicting 
postoperative complications1, 18, 23).
The anti-­inflammatory effects of propofol have 
been compared with those of other anesthetics in 
previous studies.  Several studies have dem on-­
strated that propofol attenuates the production of 
pro-­inflammatory cytokines more effectively than 
sevoflurane or midazolam8, 14, 31).  Hence, the infu-­
sion of propofol during or after surgery might result 
in smaller postoperative increases in the patient’s 
body temperature and CRP level compared with 
WKHLQKDODWLRQRIVHYRÁXUDQHRUWKHLQIXVLRQRIPLG-­
azolam.  However, to the best of our knowledge, no 
previous studies have compared the effects of pro-­
pofol on patients’ postoperative body temperature 
or CRP level with those of other anesthetics.
The aim of the present study was to examine the 
postoperative body temperature and CRP level of 
patients who underwent thoracoabdominal esopha-­
gectomy and to compare these parameters between 
patients who were subjected to propofol anesthesia 
followed by postoperative propofol sedation and 
WKRVHZKRZHUHVXEMHFWHGWRVHYRÁXUDQHDQHVWKHVLD
followed by postoperative midazolam sedation.  In 
addition, various clinical course-­related parame-­
ters were compared between the two groups.
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ABSTRACT
Responses to surgical stress can be modulated by anesthetics.  We prospectively compared the 
effects of two different anesthetic/sedative techniques on the peak postoperative bladder 
temperature (BT) and the postoperative C-­reactive protein (CRP) level.  Twenty patients who 
were scheduled to undergo elective thoracoabdominal esophagectomy were allocated to receive 
either propofol anesthesia followed by propofol sedation (PP group, n = 10) or sevoflurane 
anesthesia followed by midazolam sedation (SM group, n = 10).  In each case, the patient’s peak 
bladder temperature was measured on the morning after surgery, and their serum CRP levels 
were assessed on postoperative days (POD) 1, 2, and 3.  The patients’ postoperative clinical 
courses were also evaluated.  The peak postoperative BT (°C) (37.6 ± 0.4 vs. 38.2 ± 0.6, 
respectively;; p <0.05) and the CRP level on POD 2 (mg/dl) (14.3 ± 3.9 vs. 20.6 ± 3.9, respectively;; 
p <0.05) were lower in the PP group than in the SM group.  The peak postoperative BT was 
positively correlated with the CRP level on POD 2 (R = 0.533, p < 0.05).  There were no 
VLJQLÀFDQWGLIIHUHQFHVEHWZHHQWKHFOLQLFDOFRXUVHUHODWHGSDUDPHWHUVLQERWKJURXSV3URSRIRO
anesthesia and postoperative propofol sedation resulted in a reduced peak postoperative BT and 
lower CRP levels on POD 2 after esophagectomy than sevoflurane anesthesia followed by 
midazolam sedation.
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fentanyl.  The dosage of propofol or sevoflurane 
was adjusted according to the bispectral index (A-­
2000 monitorTM;; Aspect Medical Systems, Newton, 
MA, USA).  Fentanyl was repeatedly administered 
at intravenous doses ranging from 25-­100 Ǎg.  In 
addition, 250 mg methylprednisolone were given 
just before surgery.  During surgery, the infusion 
rate of glucose-­free Ringer’s acetate solution was 
adjusted to ensure that the patients’ urinary out-­
put remained above 0.5 ml/kg/hr, and 5% glucose 
acetate maintenance solution was infused at a rate 
of 50 ml/hr.  The patients’ blood pressure and heart 
rate were maintained within 25% of their preoper-­
ative values.  Dopamine was administered intrave-­
nously when necessary.  The temperature of the 
operation room was maintained at between 22 and 
24°C.  A warming system (WarmTouchTM, Covidi-­
en, Mansfield, MA, USA) was used to maintain 
the patients’ BT (which was measured with a Bar-­
dex Lubricath Temperature-­Sensing Foley Cathe-­
terTM;; C. R. Bard, Murray Hill, NJ, USA) within 
the normal range (36-­37°C).
After the procedure, the patients were trans-­
ferred to the intensive care unit (ICU) and were 
placed on mechanical ventilation until postopera-­
tive day (POD) 3.  Sedation was maintained with 
propofol in the PP group and with midazolam in 
the SM group with the aim of achieving a Ramsey 
sedation score25) of between 3 and 4.  The postoper-­
ative pain management strategy involved the 
nurse-­controlled intravenous administration of 25 
Ǎg/ml fentanyl (dose: 2 ml/hr for basic infusions;; 1 
ml for bolus injections;; lock-­out time: 5 min).  Post-­
operatively, the patients received 4.3% glucose ace-­
tate maintenance solution at a rate of 100 ml/hr 
until 10:00 am on POD 2, followed by a high-­calorie 
infusion containing 560 kcal/903 ml, which was de-­
livered at a rate of 60 ml/hr.  The infusion rate of 
Ringer’s acetate solution was adjusted (between 0 
and 200 ml/hr) to ensure that the patients’ urinary 
output remained above 0.5 ml/kg/hr.  The tempera-­
ture of the ICU was maintained within 25 ± 0.5°C.
Measurements
The measurement protocol employed in the opera-­
tion room and ICU is shown in Fig. 1. On the basis 
of our preliminary data, we predicted that the pa-­
tients’ BT would peak around 6 hr after surgery. 
Thus, we recorded the patients’ BT every 2 hr until 
14 postoperative hours using the Perioperative In-­
formation Management System (PIMSTM;; Royal 
Philips Electronics, Amsterdam, Noord-­Holland, 
NLD) in the ICU.  Blood samples were obtained be-­
fore and after surgery and used to determine the 
patients’ serum CRP, triglyceride, glucose and 
leptin levels.  Energy expenditure (EE) and the re-­
spiratory quotient (RQ) were assessed using indi-­
rect calorimetry (Vmax29nTM;; VIASYS Respiratory 
Care, Yorba Linda, CA, USA) at the same time as 
the blood sampling (except before the operation). 
68%-(&76$1'0(7+2'6
The protocol of this study was approved by the 
ethics committee of Hiroshima University Hospital 
(No.: 40006) and registered in the Universal Hos-­
pital Medical Information Network Clinical Trials 
Registry (ID: UMIN000009023, http://www.umin.
ac.jp/ctr).  Informed consent was obtained from all 
participating patients.  The preoperative exclusion 
criteria included a body mass index (BMI) of >30 
kg/m2;; a history of diabetes mellitus, hyperlipid-­
emia, or renal dysfunction (creatinine >1.0 mg/dl);; 
having received a high calorie infusion or chemo-­
radiotherapy within a month of surgery;; or being 
administered steroids or non-­steroidal anti-­in-­
flammatory drugs (NSAID).  A total of 24 male 
cancer patients with American Society of Anesthe-­
VLRORJLVWV3K\VLFDO6WDWXVFODVVLÀFDWLRQVRI,RU,,
who underwent elective thoracoabdominal esopha-­
gectomy and gastric tube reconstruction without 
laparoscopy at 9:00 am were enrolled into this 
prospective study.  All started fasting at midnight 
on the day of surgery, and no preanesthetic medi-­
cations were administered in any case.
The patients were divided into two groups using 
pre-­prepared sealed envelopes: the propofol anesthe-­
sia followed by propofol sedation group (PP group) 
DQGWKHVHYRÁXUDQHDQHVWKHVLDIROORZHGE\PLGD]RO-­
am sedation group (SM group).  The primary out-­
come variable was the postoperative peak bladder 
temperature (BT), which was measured early in the 
morning after the procedure.  The secondary out-­
come variables included the postoperative CRP lev-­
el;; skinfold measurements obtained with skinfold 
calipers;; and parameters related to the patients’ 
clinical courses, including the number of anasto-­
motic leaks, the number of times reintubation was 
required, the time until oral intake was re-­initiated, 
and length of the hospitalization period.
Sample size was determined based on the authors’ 
preliminary data about the peak postoperative BT of 
patients that underwent thoracoabdominal esopha-­
gectomy.  The expected inter-­group difference in 
peak BT was 0.657°C [standard deviation, 0.49].  It 
was estimated that a sample size of 10 subjects in 
HDFKJURXSZRXOGSURYLGHDQǂYDOXHRIDQG
power for detecting such inter-­group differences.
Anesthesia and intensive care management
In both groups, an arterial line was inserted 
into the left radial artery before the induction of 
anesthesia to enable repeated blood sampling and 
continuous blood pressure monitoring.  In the PP 
group, anesthesia was induced via a target-­con-­
trolled infusion of 3.0 Ǎg/ml propofol and 2.0 Ǎg/kg 
of fentanyl and was maintained with propofol and 
fentanyl.  In the SM group, anesthesia was induced 
with 3.0-­5.0 mg/kg thiamylal and 2.0 Ǎg/kg fen-­
tanyl and was maintained with sevoflurane and 
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indicate statistical significance.  All statistical 
analyses were performed with StatView 5.0 (SAS 
Institute Inc., Cary, NC, USA).
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A CONSORT flow diagram is shown in Fig. 2. 
Twenty-­four patients had their eligibility for this 
study assessed.  Four of them met one or more of 
the exclusion criteria, and so the remaining 20 pa-­
tients took part in the study;; thus, both groups 
consisted of 10 patients.  The patients’ preopera-­
tive and intraoperative data are summarized in 
Tables 1 and 2, respectively.  In the PP group, the 
intraoperative and postoperative propofol doses 
were 5.2 ± 0.8 mg/kg/hr and 73 ± 20 mg/kg/day, 
respectively.  In the SM group, the postoperative 
midazolam dose was 2.8 ± 0.8 mg/kg/day.  None of 
the patients required NSAID, beta-­adrenergic an-­
tagonists, insulin, diuretics, or dopamine >3 Ǎg/
kg/min during their stay in the ICU.
At 6, 8, and 10 hr after surgery, the mean BT of 
WKH33JURXSZDVVLJQLÀFDQWO\ORZHUWKDQWKDWRI
the SM group (Fig. 3).  The peak postoperative BT 
RIWKH33JURXSZDVDOVRVLJQLÀFDQWO\ORZHUWKDQ
that of the SM group (37.6 ± 0.4°C vs. 38.2 ± 0.6°C, 
S 7KH33JURXSH[KLELWHGDVLJQLÀFDQWO\
lower CRP level than the SM group on POD 2 (Fig. 
 &RQYHUVHO\76)ZDVVLJQLÀFDQWO\KLJKHULQ
the PP group (Table 3).  Peak postoperative BT 
was positively correlated with the CRP level on 
POD 2 (R = 0.533, p = 0.014) and negatively corre-­
lated with %TSF (R = 0.475, p = 0.033).  None of 
the other clinical course-­related parameters dif-­
IHUHGVLJQLÀFDQWO\EHWZHHQWKHWZRJURXSV7DEOH
3).  However, two patients in the SM group, whose 
temperatures became lower than 38°C on POD 2 
in the same course as the other patients’, suffered 
anastomotic leaks which were diagnosed on POD 6 
or later.  Even after the exclusion of these patients’ 
data, the inter-­group differences in peak postoper-­
Preoperative predicted basal energy expenditure 
(kcal/day) was calculated according to the Harris-­
Benedict equation: 66.47 + 13.75 × body weight (kg) 
+ 5.003 × height (cm) + 6.775 × age (years).
According to the methods described by Bishop et 
al2), arm circumference (AC, cm) and triceps skin-­
fold measurements (TSF, mm;; an indicator of sub-­
cutaneous fat mass) were obtained using skinfold 
calipers (ADIPOMETERTM;; Abbott Japan, Mita, 
Tokyo, JPN) and a tape measure on the day before 
surgery and on POD 18 (the day the patients were 
discharged from hospital if they were free from 
complications).  Arm muscle circumference (AMC), 
an indicator of skeletal muscle mass, was calculat-­
ed from AC and TSF using the following equation: 
$0& $&FPïð76)PPð7RUH-­
duce error, all of the AC and TSF measurements 
were performed by the same observer.  Five mea-­
surements were taken, and the mean of the three 
middle values was used.  Furthermore, %TSF was 
calculated using the following equation: %TSF = 
(TSF on POD 18) / (TSF on the day before surgery) 
× 100 (%). %AC and %AMC were calculated using 
similar equations.
The number of anastomotic leaks, the number of 
times reintubation was required, the time until 
oral intake was reinitiated, and the length of the 
postoperative hospitalization period were also 
recorded.
Statistical analysis
Data are expressed as mean ± SD values for 
parametric data or median (range) values for non-­
parametric data.  Inter-­group differences in individ-­
ual variables were evaluated using Student’s t-­test, 
Fisher’s exact test, or Mann-­Whitney U-­test, as ap-­
propriate.  Tukey-­Kramer test was used to correct 
for multiple comparisons.  The correlations be-­
tween peak postoperative BT and the CRP level or 
between peak postoperative BT and %TSF were 
analyzed using Pearson’s product-­moment correla-­
tion method.  p-­values of <0.05 were considered to 
)LJ Schematic diagram of the measurement protocol employed in the operation room and intensive care unit
PO: postoperative, POD: postoperative day, hr: hours.
§  Predicted resting energy expenditure according to the Harris-­Benedict equation was used as a substitute for 
energy expenditure according to indirect calorimetry.
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7DEOH Demographic data during surgery
PP group (n = 10) SM group (n = 10) 
Operative duration (hr) 7.0 ± 1.2 6.9 ± 1.5
Duration of anesthesia (hr) 8.7 ± 1.2 8.5 ± 1.6
Blood loss (ml) 809 ± 718 585 ± 424
,QWUDYHQRXVÁXLGYROXPHPONJKU 6.9 ± 1.5 7.7 ± 1.9
Glucose dose (mg/kg/hr) 49 ± 15 57 ± 17
Fentanyl dose (Ǎg/kg/hr) 5.1 ± 1.5 5.4 ± 1.7
Urinary output (ml/kg/hr) 1.3 ± 0.9 1.1 ± 0.6
Dopamine agonist treatment (n) 5 5
/\PSKQRGHGLVVHFWLRQW\SHWZRÀHOGWKUHHÀHOG 7 : 3 6 : 3*
Data are expressed as mean ± SD values for quantitative variables or as n values for qualitative variables.  
1RVLJQLÀFDQWGLIIHUHQFHVZHUHGHWHFWHGEHWZHHQWKHJURXSV
*One patient in this group did not undergo lymph node dissection
)LJ&216257ÁRZGLDJUDPIRUWKHVWXG\HQUROOPHQW
7DEOH Demographic data before surgery
PP group (n = 10) SM group (n = 10)
Age (years) 62 ± 10 67 ± 8
Height (cm) 165 ± 6 162 ± 6
Weight (kg) 67 ± 14 62 ± 8
Body mass index (kg/m2) 24.0 ± 3.9 23.5 ± 3.0
Arm circumference (cm) 25.9 ± 3.1 25.3 ± 2.2
Arm muscle circumference (cm) 23.4 ± 1.8 22.4 ± 1.6
Triceps skinfold thickness (mm) 8.2 ± 4.7 9.4 ± 4.8
pREE (kcal/m2/day) 798 ± 55 768 ± 46
Blood urea nitrogen (mg/dl) 13.3 ± 2.7 13.1 ± 3.0
Creatinine (mg/dl) 0.76 ± 0.11 0.83 ± 0.11
Hematocrit (%) 39 ± 4 37 ± 5
Albumin (g/dl) 4.0 ± 0.4 4.2 ± 0.4
Neoadjuvant chemoradiotherapy (n) 4 3
Stage (0/ I/ II/ III/ IV) (n) 2/ 3/ 2/ 3/ 0 0/ 5/ 3/ 1/ 1
'DWDDUHH[SUHVVHGDVPHDQ6'YDOXHVIRUTXDQWLWDWLYHYDULDEOHVRUDVQYDOXHVIRUTXDOLWDWLYHYDULDEOHV1RVLJQLÀFDQW
differences were detected between the groups pREE (kcal/day): Predicted resting energy expenditure according to the 
Harris-­Benedict equation;; i.e., 66.47 + 13.75 × body weight (kg) + 5.003 × height (cm) + 6.775 × age (years)
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No previous studies have detected differences be-­
tween the effects of propofol and other anesthetics 
on both postoperative body temperature and CRP 
OHYHO $PRQJVHYHUDOUHSUHVHQWDWLYHSURLQÁDPPD-­
tory cytokines, interleukin 6 (IL-­6) is known to be a 
major perioperative pyrogen4) and an important reg-­
ulator of acute phase protein production, including 
CRP production12).  A systematic review showed 
that the timing of the peak postoperative CRP level 
occurred later than that of IL-­6, between 24 and 72 
hr after major procedures30).  Although we did not 
measure the patients’ IL-­6 level in this study, 
peak postoperative BT was positively correlated 
with the CRP level on POD 2.  Taking the above 
points into account, our results suggest that pro-­in-­
flammatory cytokine production, especially IL-­6 
production, might be lower in the PP group than in 
the SM group.  Two previous studies have com-­
SDUHGWKHHIIHFWVRISURSRIRODQGVHYRÁXUDQHDQHV-­
thesia on the intraoperative IL-­6 level.  In these 
studies, it was found that propofol attenuated the 
increase in the IL-­6 level caused by surgery more 
HIIHFWLYHO\WKDQVHYRÁXUDQH 6SHFLÀFDOO\WKHVHHI-­
fects were observed prior to the initiation of cardio-­
ative BT (37.6 ± 0.4°C vs. 38.1 ± 0.7°C, p <0.05), 
the CRP level on POD 2 (14.3 ± 3.9 mg/dl vs. 20.4 ± 
4.0 mg/dl, p <0.05), and %TSF (86.9 ± 8.2% vs. 
SUHPDLQHGVLJQLÀFDQW
No differences in EE, the RQ, or the levels of 
triglycerides, glucose, or leptin were detected at 
any time point (data not shown).
',6&866,21
In this study, peak postoperative BT and the se-­
UXP&53OHYHORQ32'ZHUHVLJQLÀFDQWO\ORZHULQ
the PP group than in the SM group.  In addition, 
peak postoperative BT was correlated with the CRP 
level on POD 2.  However, there were no differences 
between the clinical course-­related parameters of 
the two groups.  Several studies have suggested 
that patients’ clinical courses after esophagectomy 
can be improved by preventing excessive surgical 
inflammation6, 9, 11, 22, 29).  In another report, fever was 
found to be independently associated with mortality 
in non-­septic patients, including those who had un-­
dergone surgery17).
)LJChanges in bladder temperature until 14 
postoperative hours in the SM and PP groups
Data are expressed as mean ± SD values.  
Pre: preoperative measurement, PO: postoperative, 
hr: hours.
SVLJQLÀFDQWGLIIHUHQFHEHWZHHQWKHJURXSV
)LJ Changes in C-­reactive protein levels after surgery in 
the SM and PP groups Data are expressed as mean ± SD 
values.  
Pre: preoperative measurement, POD: postoperative day.
SVLJQLÀFDQWGLIIHUHQFHEHWZHHQWKHJURXSV
7DEOH Secondary outcomes excluding CRP levels
 PP group (n = 10) SM group (n = 10)
% AC (%) 95.1 ± 5.2 94.0 ± 2.7
% AMC (%) 95.5 ± 5.1 95.5 ± 3.4
% TSF (%) 86.9 ± 8.2 75.2 ± 11.5*
Anastomotic leakage (n) 0 2
Reintubation (n) 0 1
Time to reinitiation of oral intake (days) 9.5 (8-­19) 10 (8-­60)
Length of hospital stay (days) 19 (18-­26) 19 (18-­88)
Data are expressed as mean ± SD, n, or median (range) values.  
AC: arm circumference, AMC: arm muscle circumference, TSF: triceps skinfold measurement
6LJQLÀFDQWO\GLIIHUHQWIURP33JURXSS
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However, in a supplementary comment, it is stated 
that the dose of propofol should be increased or 
decreased according to the status of patients on 
clinical necessity.  The dose of propofol seemed not 
to be excessive as it was needed as a clinical require-­
ment.
Limitations
The present study had several limitations.  First, 
we did not measure the patients’ IL-­6 levels.  As a 
UHVXOWZHFRXOGQRWGHÀQLWLYHO\GHWHUPLQHZKHWKHU
the differences between the peak postoperative BT 
and the CRP level of the two groups were attribut-­
able to the anti-­inflammatory effects of propofol. 
Second, the data for the SM group included data for 
two patients who suffered anastomotic leaks. 
When we re-­analyzed the data after excluding 
these patients, the differences in peak postopera-­
tive BT, the CRP level on POD 2, and %TSF re-­
PDLQHGVLJQLÀFDQW7KHUHIRUHZHFRQVLGHUWKDWRXU
findings regarding the differences between the 
groups are valid.  Third, ideally we should have 
set up another group in which the patients were 
given an intravenous infusion containing an 
equivalent amount of triglycerides to that found in 
propofol to investigate the effects of triglycerides 
on the peak postoperative BT, the CRP level, and 
%TSF.  However, it has been suggested that the 
use of triglyceride infusions during surgery can 
cause liver dysfunction or fatty liver3).  Therefore, 
we did not include such a group due to ethical con-­
siderations.
In summary, among patients who underwent 
thoracoabdominal esophagectomy the peak post-­
operative BT and the CRP level on POD 2 were 
lower in the PP group than in the SM group.  Fur-­
ther studies of the effects of different anesthetic/
sedative techniques on inflammatory responses 
are needed.
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pulmonary bypass8) and before and after one-­lung 
ventilation during lobectomy14).  However, a report 
VKRZHGWKDWVHYRÁXUDQHDWWHQXDWHGWKHLQFUHDVHLQ
IL-­6 and CRP levels after lung lobectomy more ef-­
fectively than propofol24).  Furthermore, other stud-­
ies found that there was no difference between the 
DQWLLQÁDPPDWRU\HIIHFWVRISURSRIRODQGVHYRÁX-­
rane anesthesia during open colorectal surgery or 
lung lobectomy15, 16).  Therefore, it is controversial 
whether propofol has more effective anti-­inflam-­
PDWRU\SRWHQWLDOWKDQVHYRÁXUDQH 2QWKHRWKHU
hand, Xia et al showed that propofol attenuated 
the increase in the IL-­6 level induced by surgery 
more effectively than midazolam 2 hr after the re-­
lease of aortic cross-­clamps as well as 24 hr after 
cardiac surgery31).  They concluded that propofol 
KDGJUHDWHUSRWHQWLDOWRUHGXFHLQÁDPPDWLRQWKDQ
midazolam.  Therefore, we speculate that the sig-­
QLÀFDQWLQWHUJURXSGLIIHUHQFHVLQSHDNSRVWRSHUD-­
tive BT and the CRP level on POD 2 observed in 
the present study might be attributable to the dif-­
ferent anesthetics used for sedation rather than to 
anesthesia.
In the present study, %TSF, an indicator of sub-­
FXWDQHRXVIDWPDVVZDVVLJQLÀFDQWO\KLJKHULQWKH
PP group than in the SM group.  Thus, the infusion 
of propofol might be associated with a reduction in 
endogenous lipid recruitment.  Since propofol is for-­
mulated as an emulsion containing about 10% tri-­
glycerides21), propofol infusions might attenuate fat 
hypercatabolism by supplying fat during the peri-­
operative period, when fat metabolism is considered 
to be increased27) +RZHYHUZHFRXOGQRWÀQGDQ\
evidence that the triglycerides in the propofol emul-­
sion affected perioperative fat metabolism because 
QRVLJQLÀFDQWGLIIHUHQFHVLQWKH54RUWULJO\FHULGH
levels were detected between the two groups.  Fat 
catabolism is mediated by changes in hormonal and 
sympathetic nervous system activity caused by sur-­
gical stress, e.g., increases in epinephrine, cortisol, 
and sympathetic activity accelerate lipolysis5, 7). 
Some studies have demonstrated that propofol at-­
tenuates the increases in epinephrine and cortisol 
levels induced by surgery more effectively than 
VHYRÁXUDQH19, 20) and depresses sympathetic activity 
more effectively than midazolam13).  Hence, these 
effects of propofol on perioperative hormonal and 
sympathetic activity might also be associated with 
changes in %TSF.  However, many other factors af-­
fect fat catabolism, including nutritional manage-­
ment, adipokines and hormones such as insulin 
and growth hormone5, 26).  Therefore, we cannot de-­
finitively state that the two anesthetic/sedative 
techniques directly influenced %TSF, although 
%TSF was weakly correlated with peak postopera-­
tive BT.
The mean dose of propofol for postoperative 
sedation was 73 mg/kg/day in this study, which 
was slightly over maximal recommended doses of 
3.0 mg/kg/hr in the Japanese drug package insert. 
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